| __timestamp | Geron Corporation | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 7459000 |
| Thursday, January 1, 2015 | 17831000 | 11831000 |
| Friday, January 1, 2016 | 18047000 | 25705000 |
| Sunday, January 1, 2017 | 11033000 | 46181000 |
| Monday, January 1, 2018 | 13432000 | 59497000 |
| Tuesday, January 1, 2019 | 52072000 | 65003000 |
| Wednesday, January 1, 2020 | 51488000 | 74506000 |
| Friday, January 1, 2021 | 85727000 | 126006000 |
| Saturday, January 1, 2022 | 95518000 | 126215000 |
| Sunday, January 1, 2023 | 125046000 | 120161000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, Protagonist Therapeutics, Inc. and Geron Corporation have been at the forefront, investing heavily in R&D to drive breakthroughs. From 2014 to 2023, Protagonist Therapeutics saw a staggering 1,500% increase in R&D expenses, peaking in 2022 with a 1.26 million dollar investment. Meanwhile, Geron Corporation's R&D spending surged by over 500%, reaching its zenith in 2023 with a 1.25 million dollar allocation. This trend underscores the fierce competition and commitment to innovation in the biotech sector. As these companies continue to push boundaries, their R&D investments are not just numbers but a testament to their dedication to advancing medical science and improving lives.
Comparing Innovation Spending: Eli Lilly and Company and Geron Corporation
AbbVie Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
R&D Insights: How GSK plc and Geron Corporation Allocate Funds
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Geron Corporation
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Geron Corporation
Research and Development: Comparing Key Metrics for Alkermes plc and Protagonist Therapeutics, Inc.
Research and Development Expenses Breakdown: ACADIA Pharmaceuticals Inc. vs Geron Corporation
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds
Research and Development Investment: Geron Corporation vs Galapagos NV
R&D Spending Showdown: Geron Corporation vs Evotec SE